Track topics on Twitter Track topics that are important to you
Wetherby Asset Management Inc. raised its stake in shares of Regeneron Pharmaceuticals, Inc. by 25.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,580 shares of the biopharmaceutical company's stock after buying an additional 320 shares during the period.NEXT ARTICLE
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...